Multimodal Acute Pain Management in the Parturient with Opioid Use Disorder: A Review

References

• National Institute on Drug Abuse. Drug overdose death rates. advancing addiction science. National Institutes of Health; 2023. Available from: https://nida.nih.gov/research-topics/trends-statistics/overdose-death-rates. Accessed May 14, 2023.
   Google Scholar
• Haight SC, Ko JY, Tong VT, Bohm MK, Callaghan WM. Opioid use disorder documented at delivery hospitalization-United States, 1999–2014. MMWR. 2018;67(31):845.
   PubMed Web of Science ®Google Scholar
• Malhotra T, Sheyn D, Arora KS. Opioid use disorder at delivery hospitalization in the United States: 2012–2016. Am J Addict. 2023;32(5):442–449. doi:10.1111/ajad.13417
   PubMedGoogle Scholar
• Whiteman VE, Salemi JL, Mogos MF, Cain MA, Aliyu MH, Salihu HM. Maternal opioid drug use during pregnancy and its impact on perinatal morbidity, mortality, and the costs of medical care in the United States. J Pregnancy. 2014;2014:1–8. doi:10.1155/2014/906723
   Google Scholar
• Maeda A, Bateman BT, Clancy CR, Creanga AA, Leffert LR. Opioid abuse and dependence during pregnancy: temporal trends and obstetrical outcomes. Anesthesiology. 2014;121(6):1158–1165. doi:10.1097/ALN.0000000000000472
   PubMed Web of Science ®Google Scholar
• Holbrook A, Kaltenbach K. Co-occurring psychiatric symptoms in opioid-dependent women: the prevalence of antenatal and postnatal depression. Am J Drug Alcohol Abuse. 2012;38(6):575–579. doi:10.3109/00952990.2012.696168
   PubMed Web of Science ®Google Scholar
• Goettler SM, Tschudin S. Care of drug-addicted pregnant women: current concepts and future strategies – an overview. Women's Health. 2014;10(2):167–177. doi:10.2217/WHE.14.7
   PubMedGoogle Scholar
• Howard H. Experiences of opioid-dependent women in their prenatal and postpartum care: implications for social workers in health care. Soc Work Health Care. 2016;55(1):61–85. doi:10.1080/00981389.2015.1078427
   PubMed Web of Science ®Google Scholar
• Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R CDC clinical practice guideline for prescribing opioids for pain—United States, 2022. MMWR Recomm Rep 2022;71(3):1–95. doi: 10.15585/mmwr.rr7103a1
   PubMedGoogle Scholar
• Pinto SM, Dodd S, Walkinshaw SA, Siney C, Kakkar P, Mousa HA. Substance abuse during pregnancy: effect on pregnancy outcomes. Eur J Obstetrics Gynecol Reprod Biol. 2010;150(2):137–141. doi:10.1016/j.ejogrb.2010.02.026
   PubMed Web of Science ®Google Scholar
• Armstrong MA, Gonzales Osejo V, Lieberman L, Carpenter DM, Pantoja PM, Escobar GJ. Perinatal substance abuse intervention in obstetric clinics decreases adverse neonatal outcomes. J Perinatol. 2003;23(1):3–9. doi:10.1038/sj.jp.7210847
   PubMedGoogle Scholar
• American College of Obstetricians and Gynecologists. Committee Opinion No. 633: alcohol abuse and other substance use disorders: ethical issues in obstetric and gynecologic practice. Obstetrics Gynecol. 2015;125(6):1529.
   PubMed Web of Science ®Google Scholar
• Patnode CD, Perdue LA, Rushkin M, et al. Screening for unhealthy drug use: updated evidence report and systematic review for the US preventive services task force. JAMA. 2020;323(22):2310–2328. doi:10.1001/jama.2019.21381
   PubMed Web of Science ®Google Scholar
• Unger A, Metz V, Fischer G. Opioid dependent and pregnant: what are the best options for mothers and neonates? Koren G, ed. Obstet Gynecol Int. 2012;2012:195954. doi:10.1155/2012/195954
   PubMedGoogle Scholar
• Guille C, Hall C, King C, Sujan A, Brady K, Newman R. Listening to women and pregnant and postpartum people: qualitative research to inform opioid use disorder treatment for pregnant and postpartum people. Drug Alcohol Depend Rep. 2022;3:100064. doi:10.1016/j.dadr.2022.100064
   PubMedGoogle Scholar
• Hooker SA, Sherman MD, Lonergan-Cullum M, Nissly T, Levy R. What is success in treatment for opioid use disorder? Perspectives of physicians and patients in primary care settings. J Subst Abuse Treat. 2022;141:108804. doi:10.1016/j.jsat.2022.108804
   PubMed Web of Science ®Google Scholar
• Dumas EO, Pollack GM. Opioid tolerance development: a pharmacokinetic/pharmacodynamic perspective. AAPS J. 2008;10(4):537–551. doi:10.1208/s12248-008-9056-1
   PubMed Web of Science ®Google Scholar
• Mehta V, Langford RM. Acute pain management for opioid dependent patients. Anaesthesia. 2006;61(3):269–276. doi:10.1111/j.1365-2044.2005.04503.x
   PubMed Web of Science ®Google Scholar
• Gulur P, Lee H. Opioid tolerance-a predictor of increased length of stay and higher readmission rates. Available from: www.painphysicianjournal.com. Accessed February 22, 2024.
   Google Scholar
• Williams JT, Ingram SL, Henderson G, et al. Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance. Pharmacol Rev. 2013;65(1):223–254. doi:10.1124/pr.112.005942
   PubMed Web of Science ®Google Scholar
• Illes P, Rubini P, Ulrich H, Zhao Y, Tang Y. Regulation of microglial functions by purinergic mechanisms in the healthy and diseased CNS. Cells. 2020;9(5):1108.
   PubMed Web of Science ®Google Scholar
• Eidson LN, Murphy AZ. Inflammatory mediators of opioid tolerance: implications for dependency and addiction. Peptides. 2019;115:51–58.
   PubMed Web of Science ®Google Scholar
• Understanding drug overdoses and deaths. Centers for Disease Control and Prevention. 2023. https://www.cdc.gov/drugoverdose/epidemic/index.html#print. Accessed February 28, 2024.
   Google Scholar
• Vanhouten JP, Rudd RA, Ballesteros MF, Mack KA. Drug overdose deaths among women aged 30–64 years-United States, 1999–2017. MMWR. 2019;68(1):1. doi:10.15585/mmwr.mm6801a1
   PubMed Web of Science ®Google Scholar
• Serdarevic M, Striley CW, Cottler LB. Sex differences in prescription opioid use. Curr Opin Psychiatry. 2017;30(4):238–246. doi:10.1097/YCO.0000000000000337
   PubMed Web of Science ®Google Scholar
• Back SE, Payne RL, Simpson AN, Brady KT. Gender and prescription opioids: findings from the national survey on drug use and health. Addict Behav. 2010;35(11):1001–1007. doi:10.1016/j.addbeh.2010.06.018
   PubMed Web of Science ®Google Scholar
• Goetz TG, Becker JB, Mazure CM. Women, opioid use and addiction. THE FASEB Journal. 2021;35(2):e21303. doi:10.1096/fj.202002125R
   PubMed Web of Science ®Google Scholar
• Opioid use and opioid use disorder in pregnancy committee on obstetric practice American society of addiction medicine; 2017. Available from: http://www.integration.samhsa.gov/. Accessed February 22, 2024.
   Google Scholar
• Tompkins DA, Campbell CM. Opioid-induced hyperalgesia: clinically relevant or extraneous research phenomenon? Curr Pain Headache Rep. 2011;15(2):129–136. doi:10.1007/s11916-010-0171-1
   PubMed Web of Science ®Google Scholar
• Roeckel LA, Le Coz GM, Gavériaux-Ruff C, Simonin F. Opioid-induced hyperalgesia: cellular and molecular mechanisms. Neuroscience. 2016;338:160–182. doi:10.1016/j.neuroscience.2016.06.029
   PubMed Web of Science ®Google Scholar
• Wilson SH, Hellman KM, James D, Adler AC, Chandrakantan A. Mechanisms, diagnosis, prevention and management of perioperative opioid-induced hyperalgesia. Pain Manag. 2021;11(4):405–417. doi:10.2217/pmt-2020-0105
   PubMed Web of Science ®Google Scholar
• Lee MO, Lee M, Silverman S, Hansen H, Patel V, Manchikanti L. A comprehensive review of opioid-induced hyperalgesia. Pain Physician. 2011;14:145–161. doi:10.36076/ppj.2011/14/145
   PubMed Web of Science ®Google Scholar
• Cohen S, Subak L, Brose W, Halpern J. Analgesia after cesarean delivery: patient evaluations and costs of five opioid techniques. Reg Anesth. 1991;16(3):141–149.
   PubMedGoogle Scholar
• Abuse S; Health Services Administration M. Clinical guidance for treating pregnant and parenting women with opioid use disorder and their infants. Available from: http://store.samhsa.gov. Accessed February 22, 2024.
   Google Scholar
• Higgins C, Smith BH, Matthews K. Evidence of opioid-induced hyperalgesia in clinical populations after chronic opioid exposure: a systematic review and meta-analysis. Br J Anaesth. 2019;122(6):e114–e126. doi:10.1016/j.bja.2018.09.019
   PubMed Web of Science ®Google Scholar
• Gelfman LP, Chai EJ. Chapter 8 - what special considerations should guide the safe use of methadone? In: Goldstein NE, Morrison RS, editors. Evidence-Based Practice in Palliative Medicine. W.B. Saunders; 2013:39–43. doi:10.1016/B978-1-4377-3796-7.00008-2
   Google Scholar
• Bicking Kinsey C, Baptiste-Roberts K, Zhu J, Kjerulff KH. Birth-related, psychosocial, and emotional correlates of positive maternal-infant bonding in a cohort of first-time mothers. Midwifery. 2014;30(5):e188–e194. doi:10.1016/j.midw.2014.02.006
   PubMed Web of Science ®Google Scholar
• Thigpen J, Melton ST. Neonatal abstinence syndrome: a challenge for medical providers, mothers, and society. J Pediatr Pharmacol Ther. 2014;19(3):144–146. doi:10.5863/1551-6776-19.3.144
   PubMedGoogle Scholar
• Maguire DJ, Taylor S, Armstrong K, et al. Long-term outcomes of infants with neonatal abstinence syndrome. Neonatal Netw. 2016;5:277–286. doi:10.1891/0730-0832.35.5.277
   Google Scholar
• Fill MMA, Miller AM, Wilkinson RH, et al. Educational disabilities among children born with neonatal abstinence syndrome. Pediatrics. 2018;142(3):e20180562. doi:10.1542/peds.2018-0562
   PubMed Web of Science ®Google Scholar
• Jones HE, Chisolm MS, Jansson LM, Terplan M. Naltrexone in the treatment of opioid-dependent pregnant women: the case for a considered and measured approach to research. Addiction. 2013;108(2):233–247. doi:10.1111/j.1360-0443.2012.03811.x
   PubMed Web of Science ®Google Scholar
• Devlin LA, Young LW, Kraft WK, et al. Neonatal opioid withdrawal syndrome: a review of the science and a look toward the use of buprenorphine for affected infants. J Perinatol. 2022;42(3):300–306. doi:10.1038/s41372-021-01206-3
   PubMed Web of Science ®Google Scholar
• Jones HE, Kaltenbach K, Heil SH, et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med. 2010;363(24):2320–2331. doi:10.1056/NEJMoa1005359
   PubMed Web of Science ®Google Scholar
• Martins SS, Fenton MC, Keyes KM, Blanco C, Zhu H, Storr CL. Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: longitudinal evidence from the national epidemiologic study on alcohol and related conditions. Psychol Med. 2012;42(6):1261–1272. doi:10.1017/S0033291711002145
   PubMed Web of Science ®Google Scholar
• Reports - drug enforcement administration. Front page. https://oig.justice.gov/reports/component/dea. Accessed Febryary 26, 2024.
   Google Scholar
• Doj D. Drug facts sheet: synthetic opioids; 2020.
   Google Scholar
• Soens MA, He J, Bateman BT. Anesthesia considerations and post-operative pain management in pregnant women with chronic opioid use. Semin Perinatol. 2019;43(3):149–161. doi:10.1053/j.semperi.2019.01.004
   PubMed Web of Science ®Google Scholar
• Sutton CD, Butwick AJ, Riley ET, Carvalho B. Nitrous oxide for labor analgesia: utilization and predictors of conversion to neuraxial analgesia. J Clin Anesth. 2017;40:40–45. doi:10.1016/j.jclinane.2017.04.005
   PubMed Web of Science ®Google Scholar
• Ward EN, Quaye ANA, Wilens TE. Opioid use disorders: perioperative management of a special population. Anesth Analg. 2018;127(2):539–547. doi:10.1213/ANE.0000000000003477
   PubMed Web of Science ®Google Scholar
• Recovery is possible: treatment for opioid addiction. Centers for Disease Control and Prevention. February 28, 2024. https://www.cdc.gov/drugoverdose/featured-topics/treatment-recovery.html. Accessed February 28, 2024.
   Google Scholar
• Hawkins NN, Lamon AM, Li YJ, Grotegut C, Habib AS. Analgesic use after vaginal delivery in women with perineal lacerations: a retrospective cohort study. Curr Med Res Opin. 2020;36(6):1009–1013. doi:10.1080/03007995.2020.1754185
   PubMed Web of Science ®Google Scholar
• Treat Opiod Use Disorder. Centers for Disease Control and Prevention. 2020. https://www.cdc.gov/opioids/overdoseprevention/treatment.html. Accessed February 26, 2024.
   Google Scholar
• Landau R. Post-cesarean delivery pain. Management of the opioid-dependent patient before, during and after cesarean delivery. Int J Obstet Anesth. 2019;39:105–116. doi:10.1016/j.ijoa.2019.01.011
   PubMed Web of Science ®Google Scholar
• Kohan L, Potru S, Barreveld AM, et al. Buprenorphine management in the perioperative period: educational review and recommendations from a multisociety expert panel. Reg Anesth Pain Med. 2021;46(10):840–859. doi:10.1136/rapm-2021-103007
   PubMed Web of Science ®Google Scholar
• American Society of Anesthesiologists. Practice guidelines for acute pain management in the perioperative setting; 2012. Available from: http://pubs.asahq.org/anesthesiology/article-pdf/116/2/248/255950/0000542-201202000-00011.pdf. Accessed February 22, 2024.
   Google Scholar
• Lugo RA, Satterfield KL, Kern SE. Pharmacokinetics of methadone. J Pain Palliat Care Pharmacother. 2005;19(4):13–24. doi:10.1080/J354v19n04_05
   PubMedGoogle Scholar
• Meyer M, Wagner K, Benvenuto A, Plante D, Howard D. Intrapartum and postpartum analgesia for women maintained on methadone during pregnancy. Obstetrics Gynecol. 2007;110(2 Part 1):261–266. doi:10.1097/01.AOG.0000275288.47258.e0
   PubMed Web of Science ®Google Scholar
• Blaes A, Duprez D, Defor T, et al. Angiotensin Converting Enzyme Inhibitors (ACEI) and doxorubicin pharmacokinetics in women receiving adjuvant breast cancer treatment. Springerplus. 2015;4(1). doi:10.1186/s40064-015-0802-4
   PubMedGoogle Scholar
• Kreutzwiser D, Tawfic QA. Methadone for pain management: a pharmacotherapeutic review. CNS Drugs. 2020;34(8):827–839. doi:10.1007/s40263-020-00743-3
   PubMed Web of Science ®Google Scholar
• Baker H. Illustrated Medical Dictionary. Lotus Press; 2004.
   Google Scholar
• World Health Organization, United Nations Office on Drugs and Crime, Joint United Nations Programme on HIV/AIDS. Substitution Maintenance Therapy in the Management of Opioid Dependence and HIV/AIDS Prevention: WHO/UNODC/UNAIDS Position Paper. World Health Organization; 2004.
   Google Scholar
• Khalesi S, Shemirani H, Dehghani-Tafti F. Methadone induced torsades de pointes and ventricular fibrillation: a case review. ARYA Atheroscler. 2014;10(6):339.
   PubMedGoogle Scholar
• Samhsa. TIP 63: medications for opioid use disorder. Available from: https://www.surveymonkey.com/r/KAPPFS. Accessed February 22, 2024.
   Google Scholar
• Agahi M, Shakoori V, Marashi SM. Electrocardiogram abnormality associated with methadone overdose. Sultan Qaboos Univ Med J. 2016;16(1):e113–e114. doi:10.18295/squmj.2016.16.01.022
   PubMedGoogle Scholar
• Kelty E, Hulse G. A retrospective cohort study of obstetric outcomes in opioid-dependent women treated with implant naltrexone, oral methadone or sublingual buprenorphine, and non-dependent controls. Drugs. 2017;77(11):1199–1210. doi:10.1007/s40265-017-0762-9
   PubMed Web of Science ®Google Scholar
• Fiellin DA, Pantalon MV, Chawarski MC, et al. Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence abstract. N Engl J Med. 2006;355(4):365–374.
   PubMed Web of Science ®Google Scholar
• Fiellin DA, Schottenfeld RS, Cutter CJ, Moore BA, Barry DT, O’Connor PG. Primary care–based buprenorphine taper vs maintenance therapy for prescription opioid dependence: a randomized clinical trial. JAMA Intern Med. 2014;174(12):1947–1954. doi:10.1001/jamainternmed.2014.5302
   PubMed Web of Science ®Google Scholar
• Godersky ME, Saxon AJ, Merrill JO, Samet JH, Simoni JM, Tsui JI. Provider and patient perspectives on barriers to buprenorphine adherence and the acceptability of video directly observed therapy to enhance adherence. Addict Sci Clin Pract. 2019;14(1):11. doi:10.1186/s13722-019-0139-3
   PubMedGoogle Scholar
• Wiegand SL, Stringer EM, Stuebe AM, Jones H, Seashore C, Thorp J. Buprenorphine and naloxone compared with methadone treatment in pregnancy. Obstetrics Gynecol. 2015;125(2):363–368. doi:10.1097/AOG.0000000000000640
   PubMed Web of Science ®Google Scholar
• Zedler BK, Mann AL, Kim MM, et al. Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta-analysis of safety in the mother, fetus and child. Addiction. 2016;111(12):2115–2128. doi:10.1111/add.13462
   PubMed Web of Science ®Google Scholar
• Kambia NK, Dine T, Odou P, et al. Pharmacokinetics and dialysability of naltrexone in patients undergoing hemodialysis. Eur J Drug Metab Pharmacokinet. 2004;29(4):225–230. doi:10.1007/BF03190603
   PubMed Web of Science ®Google Scholar
• Wachman EM, Saia K, Miller M, et al. Naltrexone treatment for pregnant women with opioid use disorder compared with matched buprenorphine control subjects. Clin Ther. 2019;41(9):1681–1689. doi:10.1016/j.clinthera.2019.07.003
   PubMed Web of Science ®Google Scholar
• Caritis SN, Venkataramanan R. Naltrexone use in pregnancy: a time for change. Am J Obstet Gynecol. 2020;222(1):1–2. doi:10.1016/j.ajog.2019.08.041
   PubMed Web of Science ®Google Scholar
• Ring LE, Landau R. Anesthetic management of the parturient with opioid addiction. Int Anesthesiol Clin. 2021;59(3):28–39. doi:10.1097/AIA.0000000000000323
   PubMed Web of Science ®Google Scholar
• Christian MS. Reproductive toxicity and teratology evaluations of naltrexone. J Clin Psychiatry. 1984;45(9 Pt 2):7–10.
   PubMed Web of Science ®Google Scholar
• Kelty E, Hulse G. A retrospective cohort study of birth outcomes in neonates exposed to naltrexone in utero: a comparison with methadone-, buprenorphine- and non-opioid-exposed neonates. Drugs. 2017;77(11):1211–1219. doi:10.1007/s40265-017-0763-8
   PubMed Web of Science ®Google Scholar
• Towers CV, Katz E, Weitz B, Visconti K. Use of naltrexone in treating opioid use disorder in pregnancy. Am J Obstet Gynecol. 2020;222(1):83.e1–83.e8. doi:10.1016/j.ajog.2019.07.037
   PubMed Web of Science ®Google Scholar
• Comer SD, Collins ED, Kleber HD, Nuwayser ES, Kerrigan JH, Fischman MW. Depot naltrexone: long-lasting antagonism of the effects of heroin in humans. Psychopharmacology. 2002;159(4):351–360. doi:10.1007/s002130100909
   PubMed Web of Science ®Google Scholar
• Committee on Obstetric Practice. ACOG practice bulletin no. 209 summary: obstetric analgesia and anesthesia. Obstetrics Gynecol. 2019;133(3):1.
   Web of Science ®Google Scholar
• Vora KS, Shah VR, Patel B, Parikh GP, Butala BP. Postoperative analgesia with epidural opioids after cesarean section: comparison of sufentanil, morphine and sufentanil-morphine combination. J Anaesthesiol Clin Pharmacol. 2012;28(4):491–495. doi:10.4103/0970-9185.101935
   PubMedGoogle Scholar
• Lazzari C, Raffaelli R, D’Alessandro R, et al. Effects of neuraxial analgesia technique on labor and maternal–fetal outcomes: a retrospective study. Arch Gynecol Obstet. 2023;307(4):1233–1241. doi:10.1007/s00404-022-06600-6
   PubMed Web of Science ®Google Scholar
• Singh NP, Makkar JK, Jafra A, Verma P, Singh PM. The effect of two groups of intrathecal fentanyl doses on analgesic outcomes and adverse effects in parturients undergoing cesarean delivery: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis. Int J Obstet Anesth. 2022;50:103270. doi:10.1016/j.ijoa.2022.103270
   PubMed Web of Science ®Google Scholar
• Hoyt MR, Shah U, Cooley J, Temple M. Use of epidural clonidine for the management of analgesia in the opioid addicted parturient on buprenorphine maintenance therapy: an observational study. Int J Obstet Anesth. 2018;34:67–72. doi:10.1016/j.ijoa.2018.01.001
   PubMed Web of Science ®Google Scholar
• Sultan P, Sultan E, Carvalho B. Regional anaesthesia for labour, operative vaginal delivery and caesarean delivery: a narrative review. Anaesthesia. 2021;76(S1):136–147. doi:10.1111/anae.15233
   PubMedGoogle Scholar
• Anderson D. Pudendal nerve block for vaginal birth. J Midwifery Women's Health. 2014;59(6):651–659. doi:10.1111/jmwh.12222
   PubMed Web of Science ®Google Scholar
• Nedeljkovic SS, Kett A, Vallejo MC, et al. Transversus abdominis plane block with liposomal bupivacaine for pain after cesarean delivery in a multicenter, randomized, double-blind, controlled trial. Anesth Analg. 2020;131(6):1830–1839. doi:10.1213/ANE.0000000000005075
   PubMed Web of Science ®Google Scholar
• Hernandez MC, Finnesgard EJ, Aho JM, Zielinski MD, Schiller HJ. Reduced opioid prescription practices and duration of stay after TAP block for laparoscopic appendectomy. J Gastrointestinal Surg. 2020;24(2):418–425. doi:10.1007/s11605-018-04100-0
   PubMed Web of Science ®Google Scholar
• Villadiego L, Baker BW. Improving pain management after cesarean birth using transversus abdominis plane block with liposomal bupivacaine as part of a multimodal regimen. Nurs Women's Health. 2021;25(5):357–365. doi:10.1016/j.nwh.2021.07.009
   PubMedGoogle Scholar
• Habib AS, Nedeljkovic SS, Horn JL, et al. Randomized trial of transversus abdominis plane block with liposomal bupivacaine after cesarean delivery with or without intrathecal morphine. J Clin Anesth. 2021;75:110527. doi:10.1016/j.jclinane.2021.110527
   PubMed Web of Science ®Google Scholar
• Baker BW, Villadiego LG, Lake YN, et al. Transversus abdominis plane block with liposomal bupivacaine for pain control after cesarean delivery: a retrospective chart review. J Pain Res. 2018;11:3109–3116. doi:10.2147/JPR.S184279
   PubMed Web of Science ®Google Scholar
• Xu M, Tang Y, Wang J, Yang J. Quadratus lumborum block for postoperative analgesia after cesarean delivery: a systematic review and meta-analysis. Int J Obstet Anesth. 2020;42:87–98. doi:10.1016/j.ijoa.2020.02.005
   PubMed Web of Science ®Google Scholar
• Blanco R, Ansari T, Riad W, Shetty N. Quadratus lumborum block versus transversus abdominis plane block for postoperative pain after cesarean delivery: a randomized controlled trial. Reg Anesth Pain Med. 2016;41(6):757. doi:10.1097/AAP.0000000000000495
   PubMed Web of Science ®Google Scholar
• Mitchell KD, Smith CT, Mechling C, Wessel CB, Orebaugh S, Lim G. A review of peripheral nerve blocks for cesarean delivery analgesia. Reg Anesth Pain Med. 2020;45(1):52–62. doi:10.1136/rapm-2019-100752
   Web of Science ®Google Scholar
• Sangkum L, Thamjamrassri T, Arnuntasupakul V, Chalacheewa T. The current consideration, approach, and management in postcesarean delivery pain control: a narrative review. Anesthesiol Res Pract. 2021;2021. doi:10.1155/2021/2156918
   PubMed Web of Science ®Google Scholar
• Bryant AS, Miller RS. Pharmacologic stepwise multimodal approach for postpartum pain management. Am Coll Obstet Gynecol. 2021;1:1.
   Google Scholar
• Towers CV, Shelton S, van Nes J, et al. Preoperative cesarean delivery intravenous Acetaminophen treatment for postoperative pain control: a randomized double-blinded placebo control trial. Am J Obstet Gynecol. 2018;218(3):353.e1–353.e4. doi:10.1016/j.ajog.2017.12.203
   PubMed Web of Science ®Google Scholar
• Ng QX, Loke W, Yeo WS, Chng KYY, Tan CH. A meta-analysis of the utility of preoperative intravenous paracetamol for post-caesarean analgesia. Medicina. 2019;55(8). doi:10.3390/medicina55080424
   Google Scholar
• Abushanab D, Al-Badriyeh D. Efficacy and safety of ibuprofen plus paracetamol in a fixed-dose combination for acute postoperative pain in adults: meta-analysis and a trial sequential analysis. CNS Drugs. 2021;35(1):105–120. doi:10.1007/s40263-020-00777-7
   PubMed Web of Science ®Google Scholar
• Chang RW, Tompkins DM, Cohn SM. Are NSAIDs Safe? Assessing the risk-benefit profile of nonsteroidal anti-inflammatory drug use in postoperative pain management. Am Surg. 2020;87(6):872–879. doi:10.1177/0003134820952834
   PubMed Web of Science ®Google Scholar
• Bongiovanni T, Lancaster E, Ledesma Y, et al. Systematic review and meta–analysis of the association between non–steroidal anti–inflammatory drugs and operative bleeding in the perioperative period. J Am Coll Surg. 2021;232(5):765–790.e1. doi:10.1016/j.jamcollsurg.2021.01.005
   PubMed Web of Science ®Google Scholar
• Urman RD, Boing EA, Pham AT, et al. Improved outcomes associated with the use of intravenous acetaminophen for management of acute post-surgical pain in cesarean sections and hysterectomies. J Clin Med Res. 2018;10(6):499–507. doi:10.14740/jocmr3380w
   PubMedGoogle Scholar
• McKenzie CP, Cobb B, Riley ET, Carvalho B. Programmed intermittent epidural boluses for maintenance of labor analgesia: an impact study. Int J Obstet Anesth. 2016;26:32–38. doi:10.1016/j.ijoa.2015.11.005
   PubMed Web of Science ®Google Scholar
• Engelman E, Marsala C. Efficacy of adding clonidine to intrathecal morphine in acute postoperative pain: meta-analysis. Br J Anaesth. 2013;110(1):21–27. doi:10.1093/bja/aes344
   PubMed Web of Science ®Google Scholar
• Huntoon M, Eisenach JC, Boese P. Epidural clonidine after cesarean section appropriate dose and effect of prior local anesthetic. Anesthesiology. 1992;76(2):187–193. doi:10.1097/00000542-199202000-00005
   PubMed Web of Science ®Google Scholar
• Lavand’homme PM, Roelants F, Waterloos H, Collet V, De Kock MF. An evaluation of the postoperative antihyperalgesic and analgesic effects of intrathecal clonidine administered during elective cesarean delivery. Anesth Analg. 2008;107(3):948–955. doi:10.1213/ane.0b013e31817f1595
   PubMed Web of Science ®Google Scholar
• De Kock M, Gautier P, Fanard L, Luc Hody J, Lavand’homme P. Intrathecal ropivacaine and clonidine for ambulatory knee arthroscopy: a Dose–Response Study. Anesthesiology. 2001;94(4):574–578. doi:10.1097/00000542-200104000-00008
   PubMed Web of Science ®Google Scholar
• Matthews L, Lim G. Analgesia in pregnancy. Obstet Gynecol Clin North Am. 2023;50(1):151–161. doi:10.1016/j.ogc.2022.10.016
   PubMed Web of Science ®Google Scholar
• Thomas DD, Liu X, Kantrow SP, Lancaster JR. The biological lifetime of nitric oxide: implications for the perivascular dynamics of NO and O 2. Proc Natl Acad Sci. 2001;98(1):355. doi:10.1073/pnas.98.1.355
   PubMed Web of Science ®Google Scholar
• Lucas DN, Siemaszko O, Yentis SM. Maternal hypoxaemia associated with the use of entonox® in labour. Int J Obst Anesth. 2000;9(4):270–272.
   PubMed Web of Science ®Google Scholar
• Ljungblad UW, Lindberg M, Eklund EA, Saeves I, Bjørke-Monsen AL, Tangeraas T. Nitrous oxide in labour predicted newborn screening total homocysteine and is a potential risk factor for infant vitamin B12 deficiency. Acta Paediatr. 2022;111(12):2315–2321. doi:10.1111/apa.16530
   PubMed Web of Science ®Google Scholar
• Broughton K, Clark AG, Ray AP. Nitrous oxide for labor analgesia: what we know to date. Ochsner J. 2020;20(4):419–421. doi:10.31486/toj.19.0102
   PubMed Web of Science ®Google Scholar
• Dinis-Oliveira RJ. Metabolism and metabolomics of ketamine: a toxicological approach. Forensic Sci Res. 2017;2(1):2–10. doi:10.1080/20961790.2017.1285219
   PubMed Web of Science ®Google Scholar
• Behdad S, Hajiesmaeili MR, Abbasi HR, Ayatollahi V, Khadiv Z, Sedaghat A. Analgesic effects of intravenous ketamine during spinal anesthesia in pregnant women undergone Caesarean section; a randomized clinical trial. Anesth Pain Med. 2013;3(2):230–233. doi:10.5812/aapm.7034
   PubMedGoogle Scholar
• Majdinasab E, Datta P, Krutsch K, Baker T, Hale TW. Pharmacokinetics of ketamine transfer into human milk. J Clin Psychopharmacol. 2023;43(5):407–410. doi:10.1097/JCP.0000000000001711
   PubMed Web of Science ®Google Scholar
• Wolfson P, Cole R, Lynch K, et al. The pharmacokinetics of ketamine in the breast milk of lactating women: quantification of ketamine and metabolites. J Psychoact Drugs. 2023;55(3):354. doi:10.22541/au.161325028.80476344/v1
   PubMed Web of Science ®Google Scholar
• Gabriel RA, Swisher MW, Sztain JF, Furnish TJ, Ilfeld BM, Said ET. State of the art opioid-sparing strategies for post-operative pain in adult surgical patients. Expert Opin Pharmacother. 2019;20(8):949–961. doi:10.1080/14656566.2019.1583743
   PubMed Web of Science ®Google Scholar
• Gomes T, Juurlink DN, Antoniou T, Mamdani MM, Paterson JM, van den Brink W. Gabapentin, opioids, and the risk of opioid-related death: a population-based nested case–control study. PLoS Med. 2017;14(10):e1002396. doi:10.1371/journal.pmed.1002396
   PubMed Web of Science ®Google Scholar
• Ende HB, Bauchat JR, Sorabella LL, et al. Post-cesarean gabapentin is not associated with lower opioid consumption or pain scores in women on chronic buprenorphine therapy: a 10-year retrospective cohort study. J Clin Anesth. 2022:77. doi:10.1016/j.jclinane.2021.110600
   Web of Science ®Google Scholar
• Hah J, Mackey SC, Schmidt P, et al. Effect of perioperative gabapentin on postoperative pain resolution and opioid cessation in a mixed surgical cohort: a randomized clinical trial. JAMA Surg. 2018;153(4):303–312. doi:10.1001/jamasurg.2017.4915
   PubMed Web of Science ®Google Scholar
• Felder L, Saccone G, Scuotto S, et al. Perioperative gabapentin and post cesarean pain control: a systematic review and meta-analysis of randomized controlled trials. Eur J Obstetrics Gynecol Reprod Biol. 2019;233:98–106. doi:10.1016/j.ejogrb.2018.11.026
   PubMed Web of Science ®Google Scholar
• El Kenany S, El Tahan MR. Effect of preoperative pregabalin on post-caesarean delivery analgesia: a dose-response study. Int J Obstet Anesth. 2016;26:24–31. doi:10.1016/j.ijoa.2015.11.001
   PubMed Web of Science ®Google Scholar
• Savelloni J, Gunter H, Lee KC, et al. Risk of respiratory depression with opioids and concomitant gabapentinoids. J Pain Res. 2017;10:2635–3641. doi:10.2147/JPR.S144963
   PubMed Web of Science ®Google Scholar
• DeLisle A, Jones HE, Jansson LM. Gabapentin use during pregnancy and lactation with and without concurrent opioid exposure: considerations and future directions. J Addict Med. 2023;17(2):123–125. doi:10.1097/ADM.0000000000001065
   PubMed Web of Science ®Google Scholar
• Shawahna R, Zaid L. Concentrations of antiseizure medications in breast milk of lactating women with epilepsy: a systematic review with qualitative synthesis. Seizure. 2022;98:57–70. doi:10.1016/j.seizure.2022.03.017
   PubMed Web of Science ®Google Scholar
• National Institute on Drug Abuse. NIDA. Is naloxone accesible? Available from: https://nida.nih.gov/publications/research-reports/medications-to-treat-opioid-addiction/naloxone-accessible. Accessed May 14, 2023.
   Google Scholar
• Rzasa Lynn R, Galinkin JL. Naloxone dosage for opioid reversal: current evidence and clinical implications. Ther Adv Drug Saf. 2018;9(1):63–88. doi:10.1177/2042098617744161
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health and Human Services, Administration for Children and Families, Children’s Bureau. Plans of Safe Care for Infants with Prenatal Substance Exposure and Their Families; 2020. Available from: www.acf. Accessed February 22, 2024.
   Google Scholar
• Wilder C, Lewis D, Winhusen T. Medication assisted treatment discontinuation in pregnant and postpartum women with opioid use disorder. Drug Alcohol Depend. 2015;149:225–231. doi:10.1016/j.drugalcdep.2015.02.012
   PubMed Web of Science ®Google Scholar
• Frankeberger J, Jarlenski M, Krans EE, Coulter RWS, Mair C. Opioid use disorder and overdose in the first year postpartum: a rapid scoping review and implications for future research. Matern Child Health J. 2023;27(7):1140–1155. doi:10.1007/s10995-023-03614-7
   PubMed Web of Science ®Google Scholar
• Martin CE, Almeida T, Thakkar B, Kimbrough T. Postpartum and addiction recovery of women in opioid use disorder treatment: a Qualitative Study. Subst Abus. 2022;43(1):389–396. doi:10.1080/08897077.2021.1944954
   PubMed Web of Science ®Google Scholar